Significant increase in volume has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The NSE noticed unusually high trading volume in shares of Sun Pharma Advanced Research Company (SPARC) and has written to the company seeking clarification. The exchange stated this step was taken to ensure investors have the latest relevant information and to protect their interests. The company has not yet responded to the exchange's query. Until a clarification is issued, the reason behind the sudden volume spike remains unknown.
Volume-based queries from the exchange are generally routine and do not necessarily imply wrongdoing, but the absence of a company response may keep the stock volatile. Retail investors should wait for SPARC's official clarification before drawing any conclusions.